| Financial Year |
March 31 2023 |
| Monetary Funds |
10,354,283,658.74 |
| Held-for-trading Financial Assets |
1,750,000,000.00 |
| Notes Receivable |
2,328,703.41 |
| Accounts Receivable |
1,373,136,635.57 |
| Advances to Suppliers |
32,837,982.43 |
| Other Receivables |
117,923,135.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,645,694,096.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
57,968,811.16 |
| Total Current Assets |
17,336,140,919.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
203,687,652.66 |
| Investment Properties |
331,965,360.15 |
| Fixed Assetes |
3,184,316,124.56 |
| Under-construction Projects |
124,866,159.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
793,514,733.55 |
| R&D expenses |
11,027,858.89 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
71,766,791.10 |
| Deferred Income Tax Assets |
12,483,603.62 |
| Other Non-Current Assets |
117,834,593.77 |
| Sub-Total of Non-Current Assets |
5,133,097,459.22 |
| Total Assets |
22,469,238,378.48 |
| Short-Term Loans |
8,010,633.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
17,320,045.37 |
| Accounts Payable |
6,785,302,136.53 |
| Accounts Received In Advance |
46,706,936.66 |
| Employee Compensation Payable |
489,522,451.97 |
| Taxes Payable |
35,807,049.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
743,445,989.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,508,212.21 |
| Other Current Liabilities |
6,717,332.24 |
| Sub-Total of Current Liabilities |
9,179,430,778.72 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
221,795,249.18 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,813,569.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
396,697,284.84 |
| Total Liabilities |
9,576,128,063.56 |
| Paid-In Capital(Or Share Stock) |
2,222,222,223.00 |
| Capital Surplus |
4,989,194,094.66 |
| Surplus Reserve |
300,787,150.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,344,081,702.78 |
| Minority Stockholder's Interest |
42,759,133.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,850,351,181.64 |
| Owner's Equity（Stockholder's Equity） |
12,893,110,314.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,469,238,378.48 |
